Insights From Cardiovascular Outcome Trials with Novel Antidiabetes Agents: What Have We Learned? An Industry Perspective

Overview of attention for article published in Current Diabetes Reports, September 2015

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 36 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 13,227 followers.

RT @ruruuuuwn: HbA1c値の差は薬物およびプラセボ群との間で達成として、CV転帰に糖毒性の減少の影響を排除するためCVOTsための前提条件であり、研究の終了時に0.3％を超えてはならない。 https://t.co/0Yr0FMwsVS おもひろい。ザクザクおも…

Reply Repost Favourite